THY1 and Parkinson disease: For example, intranasal carnosine (approximately 2–4 mg per day for 8 weeks) significantly improved motor function and reduced α-synuclein aggregation in a transgenic mouse model of Parkinson's disease (PD) (Thy1-aSyn), highlighting effective brain delivery and preventing the peripheral degradation due to circulating carnosinases [176].